Melanoma May No Longer Be a Death Sentence

June 3 (Bloomberg) -- The next generation of experimental immune-boosting drugs from Merck, Bristol-Myers and Roche are producing such promising early results that doctors are openly speculating that some patients with the deadliest form of skin cancer may be cured. Olivia Sterns reports on Bloomberg Television's "Street Smart." (Source: Bloomberg)

The Impact of Global Monetary Policy on Currencies
13:06 - David Bloom, global head of FX research at HSBC, discusses monetary policy coming from both the Federal Reserve and ECB, and their impact on currencies. He speaks with Jonathan Ferro on Bloomberg Television’s “On The Move.” (Source: Bloomberg)
  • Do Investors Have an Appetite for Riskier Assets?
  • Vedanta CEO Says China Is in a Double Structural Shift
  • Investing in Renewables: Where Are the Opportunities?